Cargando...
Factors Associated With Drug Consumption Without Scientific Evidence in Patients With Mild COVID-19 in Peru
Author(s)
Soriano‐Moreno, David R.
Fernandez‐Guzman, Daniel
Universidad San Ignacio de Loyola
Sangster-Carrasco, Lucero
Peruvian University of Applied Sciences
Quispe‐Vicuña, Carlos
National University of San Marcos
Grados‐Espinoza, Pamela
Daniel Alcides Carrión National University
Ccami‐Bernal, Fabricio
Universidad Nacional de San Agustin de Arequipa
Morocho-Alburqueque, Noelia
Universidad Nacional de Piura
Coba-Villan, Naomi
National University of Cajamarca
Velasquez-Fernandez, Randy
Universidad San Ignacio de Loyola
Nieto-Gutierrez, Wendy
Universidad San Ignacio de Loyola
Date Issued
20 de julio de 2022
Type
Article
Volume
18
Issue
8
Series/Report No.
Journal of Patient Safety
Start Page
e1189
End Page
e1195
ISSN
1549-8417
1549-8425
Abstract
OBJECTIVE: This study aimed to evaluate the factors associated with the consumption of drugs without scientific evidence in patients with mild COVID-19 infection in Peru. METHODS: An analytical cross-sectional study was carried out including 372 adult patients with a history of mild COVID-19 disease. Factors associated with drug consumption were evaluated by Poisson regressions with robust variance adjustment using the bootstrapping resampling method. RESULTS: Seventy-two percent consumed some medication without scientific evidence, with antibiotics (71%) and ivermectin for human use (68%) being the most commonly used. Factors associated with the consumption of drugs to treat mild COVID-19 infection were thinking that the drugs are not effective (adjusted prevalence ratio, 0.55; 95% confidence interval, 0.41-0.74) and not being informed about the efficacy of the drugs (adjusted prevalence ratio, 0.48; 95% confidence interval, 0.36-0.65). CONCLUSIONS: Education of the population seems to be the main factor that increases the consumption of drugs without scientific evidence in the Peruvian population to treat mild COVID-19.
Keywords